Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast Cancer
James W. Purcell(Barrow Neurological Institute), Sylvaine Cases(Gladstone Institutes), Joe W. Gray(University of Newcastle Australia), Heidi S. Feiler(Oregon Health & Science University), Shamra Martin(Lawrence Berkeley National Laboratory), Hung Quoc Vo(Lawrence Berkeley National Laboratory), Jessica I. Billig(Southwestern Medical Center), Peter Bean(Lawrence Berkeley National Laboratory), Safiyyah Ziyad(Bristol-Myers Squibb (United States)), Karen Louise Thomsen(University College Hospital), Wen Lin Kuo(Lawrence Berkeley National Laboratory), Mamatha Reddy(Lawrence Berkeley National Laboratory), Kenneth W. Wood(Cytokinetics (United States)), Kimberly Samayoa(Lawrence Berkeley National Laboratory)
Cited by 95
Related Papers
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|602
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
|Journal of Clinical Investigation|2012|591
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
|Cancer Cell|2013|571
Subtype and pathway specific responses to anticancer compounds in breast cancer
|Proceedings of the National Academy of Sciences|2011|505